- 4-Week # shares sold: 4,000
- 12-Week # shares sold: 13,000
- 24-Week # shares sold: 18,000
- 4-Week # shares sold: 355,634
- 12-Week # shares sold: 2.0 million
- 24-Week # shares sold: 3.7 million
- 24-Week # shares sold: 10,986
The beaten down biotech sector may offer more opportunities in this newly volatile market environment.
Jim Cramer maps out what investors need to find a way back to the upside, including the Fed, interest rates and earnings.
Jim Cramer takes a closer look at Walt Disney Co., RH, Immunogen, and Advanced Micro Devices.
In the wake of Trump's blocking the Broadcom-Qualcomm deal, Jim Cramer ask if we should be worried that all of tech that wants to be big in China could be under pressure.
Jim Cramer looks at the investment strategies you need to use throughout your life, especially in a volatile market.